Current NEWS
September 30, 2020– U.S. FDA Grants GI Windows Medical Corp, Breakthrough Device Designation for Magnetic Anastomosis Technology
August 19, 2020– GI Windows Corp, a clinical-stage, privately-held medical device company, announced a $16.4 million Series A-1. The financing attracted Johnson & Johnson Innovation - JJDC, along with Sonder Capital, GT Healthcare, JC Investco and one additional strategic investor.
December 12, 2019– GI Windows Corp, a clinical-stage, privately-held medical device company, announced a $14.6 million Series A financing
Media Contact:
David Karasek